A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure



Status:Recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:3/24/2019
Start Date:January 30, 2018
End Date:December 30, 2019
Contact:Rachel Ojha
Email:Rachel.Ojha@nutricia.com
Phone:301-795-2259

Use our guide to learn which trials are right for you!

A Prospective, Open Label, Multi-site Study in North America to Evaluate the Effects of a New Ready-to-feed, Nutrient Dense Formula on the Growth, Safety and Tolerance of Infants With Growth Failure

This study is a prospective, open-label, multi-site, growth, safety and tolerance study to
evaluate a NF (New Formula). A minimum of 45 evaluable infants with confirmed growth failure
will be enrolled. Growth failure for 30 infants will be due to congenital heart disease and
15 infants due to other organic or non-organic causes. Study infants (in-patient or living
with parents/ caregivers at home) will be fed the NF for a period of up through 16 weeks or
until the time the infant subject meets criteria for switching to a lower calorie density
formula, relative to baseline in infants with growth failure. Weight, height, head
circumference and mid upper arm circumference will be measured regularly throughout the
study. NF and other food intake, tolerance and stool diaries will be completed regularly.
Serious adverse and adverse events will be monitored throughout the study. Infants will be
evaluated, at each study visit, for criteria to switch to a lower calorie density formula.
The primary objective is to improve weight-for-age z score relative to baseline. The
secondary objectives are to improve weight-for-length, length-for-age, head
circumference-for-age, mid upper arm circumference-for-age, weight velocity and length
velocity z scores relative to baseline.


Inclusion Criteria:

1. Infants must have attained term gestation (≥37 weeks of gestational age) at the time
of screening

2. Infants, male or female, aged 1 through 8 months

3. Infants with congenital heart disease or other organic/non-organic cause of growth
failure with a weight-for-length z score ≤ -1.0 or weight gain ≤ -2.0 z score based on
WHO growth standards. (for weight gain metrics please see Appendix I): Weight gain (g)
for boys and girls by age ( -2 z scores for weight velocity). Infants with Down
syndrome must have a weight for length z-score ≤-1.0 z score. Infants with Down
syndrome who meet the weight gain criterion (≤ -2.0 z-score weight gain) and have a
weight for length z-score >-1.0 z-score will not be eligible for enrolment.

4. Infants expected to consume (or obtain via tube feeding), on average, 80% of their
total energy intake from NF for 16 weeks

5. Infants from families who are willing and able to have anthropometrics taken at the
required frequency as well as to comply with all other protocol requirements

6. Written informed consent from the parent/caregiver or legal guardian

7. Parent/caregiver or legal guardian must be able to read, write, and understand English

Exclusion Criteria:

1. Infants with known or suspected complex gastrointestinal anomalies or dysfunction,
hepatic* or renal* dysfunction, or inherited metabolic disorders, congenital
neurological insults, suspected or diagnosed conditions associated with malabsorption
(e.g. cystic fibrosis)

2. Infants with known or suspected systemic or congenital infections (e.g. human
immunodeficiency virus, HBV, HCV)

3. 3. Infants with known or suspected genetic conditions listed in Appendix VI and/or
metabolic conditions known to interfere with growth or body dysmorphology that can
interfere with obtaining standard anthropometric measurements (weight, length, head
circumference, and mid upper arm circumference), with the exception of infants
diagnosed with Down syndrome who may be enrolled in the study

4. Infants with known or suspected cow milk allergy or children who have received cow
milk formula for 7 days or less

5. Infants expected to consume on average more than 20% of their energy intake from
non-NF sources of nutrition: solids, expressed breast milk and /or parenteral
nutrition.

6. Child feeding directly at the breast more than twice per day

7. Infants participating in any other studies involving investigational or marketed
products concomitantly or within two weeks prior to the entry into the study. Infants
participating in vaccination trials, who are only receiving follow-up blood
monitoring, are not excluded.

8. Principal Investigator's uncertainty about the willingness or ability of the
parent/caregiver or legal guardian to comply with the protocol requirements

9. Infants whose parent is younger than the legal age of consent

10. Infants born large for gestational age (LGA). LGA: Birth weight > 90th percentile for
gestational age (please see chart in Appendix I)

11. Infants born small for gestational age (SGA). SGA: Birth weight < 10th percentile for
gestational age (please see chart in Appendix I) * Note: For hepatic dysfunction, a
conjugated bilirubin >2.0 mg/dL and for renal dysfunction child should not meet any of
the pRIFLE criteria for renal disease (estimated creatinine clearance decreased by 25%
by the Schwartz formula or urine output <0.5 mL/kg per hour over the previous 8 or
more hours) or has chronic medical renal disease. In most children labs need not be
obtained. These criteria only come into play when there is a consideration of liver or
renal disease in the individual child.
We found this trial at
5
sites
1 Medical Center Blvd
Winston-Salem, North Carolina 27103
(336) 716-2011
Wake Forest University Baptist Medical Center Welcome to Wake Forest Baptist Medical Center, a fully...
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
993 Johnson Ferry Road Northeast
Atlanta, Georgia 30342
Phone: 404-257-2279
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1001 E 5th St
Greenville, North Carolina 27858
(252) 328-6131
East Carolina University Whether it's meeting the demand for more teachers and healthcare professionals or...
?
mi
from
Greenville, NC
Click here to add this to my saved trials
Jacksonville, Florida 32207
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
8701 W Watertown Plank Rd
Milwaukee, Wisconsin
(414) 955-8296
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials